Skip to content
Screener

Ranpak Holdings PACK Europe/Asia — Net product revenue

Other segment segments

North America
$45.9M+8.5%

Similar metrics at other companies

Krystal Biotech, Inc. logo
KRYSEurope — Product revenue, net
$20.68M
Vertex Pharmaceuticals logo
VRTXEurope — Product revenues, net
$950M+14.9%
Resources Connection, Inc. logo
RGPEurope & Asia Pacific — Revenue
$17.09M-19.9%
Corcept Therapeutics logo
CORTHypercortisolism Products — Product revenue, net
$208.58M+7.3%
TechnipFMC logo
FTIEurope and Central Asia — Revenue
$477.3M-6.4%
Byrna Technologies, Inc. logo
BYRNEurope South America Asia — Revenue
$555K-80.7%

Other financials

Income statement

See full
Revenue$105.2M+14.0%
Gross profit$34.5M+19.4%
Operating income-$2.4M+75.3%
Net income-$7.9M-5.3%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$43.2M-12.2%
Total debt$429.7M-0.8%
Total equity$519.9M-3.5%
Total assets$1.1B-3.6%

Cash flow

See full
Operating cash flow$2.7M+175%
CapEx$2.7M+42.1%
Free cash flow$3.5M+333%

Valuation

See full
Market cap$472.53M+31.2%
Enterprise value$859.03M+15.0%
P/S1.1×+0.2×

Profitability

See full
Gross margin33.6%-2.0pp
Operating margin-3.1%
Net margin-9.1%-0.6pp
FCF margin6.1%-2.5pp

Returns & leverage

See full
Return on equity-7.2%+0.5pp
Debt / equity0.8×0.0×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Ranpak Holdings in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: Ranpak Holdings’s 10-Q, filed July 30, 2026.

Filed
Jul 30, 2026, 9:01 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050839
Line itemThree Months Ended June 30, 2026 / North AmericaThree Months Ended June 30, 2026 / Europe/AsiaThree Months Ended June 30, 2026 / ConsolidatedSix Months Ended June 30, 2026 / North AmericaSix Months Ended June 30, 2026 / Europe/AsiaSix Months Ended June 30, 2026 / Consolidated
Net product revenue$36.5$49.9$86.4$69.6$98.6$168.2
Machine lease revenue9.49.418.818.819.438.2
Net revenue45.959.3105.288.4118.0206.4
Less:
Cost of sales excluding depreciation and amortization30.533.058.663.4
Compensation expense(1)12.515.125.830.8
Professional fees2.01.04.02.0
Stock-based compensation0.90.32.10.4

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Ranpak Holdings's europe/asia — net product revenue?
Ranpak Holdings (PACK) reported europe/asia — net product revenue of $59.3M in Q2 2026.
How has Ranpak Holdings's europe/asia — net product revenue changed year-over-year?
Ranpak Holdings's europe/asia — net product revenue increased by 18.6% year-over-year, from $50M to $59.3M.
What is the long-term trend for Ranpak Holdings's europe/asia — net product revenue?
Over 4 years (2021 to 2025), Ranpak Holdings's europe/asia — net product revenue has grown at a -3.1% compound annual growth rate (CAGR), from $237M to $209M.
What does europe/asia — net product revenue mean?
This metric represents the total revenue generated from the sale of physical goods within the Europe and Asia geographic segment. It reflects the core demand for protective packaging consumables and products in these specific markets. Tracking this helps investors assess the market penetration and sales performance of the company's primary product offerings in international regions.

Ask your AI about Ranpak Holdings's europe/asia — net product revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude